BMS986187

CAS No. 684238-37-7

BMS986187( —— )

Catalog No. M24699 CAS No. 684238-37-7

BMS986187 is a novel Potent and Selective Positive Allosteric Modulators of the delta-Opioid Receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 68 In Stock
10MG 110 In Stock
25MG 215 In Stock
50MG 312 In Stock
100MG 484 In Stock
500MG 1035 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS986187
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS986187 is a novel Potent and Selective Positive Allosteric Modulators of the delta-Opioid Receptor.
  • Description
    BMS986187 is a novel Potent and Selective Positive Allosteric Modulators of the delta-Opioid Receptor.
  • In Vitro
    BMS-986187?(1 nM-100 uM) produces little or no activity in agonist mode, but in PAM mode (in the presence of an EC20?of leu-enkephalin (in CHO-OPRD1 cells) or endomorphin 1 (in CHO-OPRM1 cells)) produces a response with an EC50?of 48 nM in CHO-OPRD1 cells and 2?μM in CHO-OPRM1 cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    δ-opioid receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    684238-37-7
  • Formula Weight
    470.6
  • Molecular Formula
    C31H34O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC1=CC=CC=C1COC2=CC=C(C=C2)C3C4=C(CC(CC4=O)(C)C)OC5=C3C(=O)CC(C5)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Livingston K E , Stanczyk M A , Burford N , et al. Pharmacological Evidence for a Putative Conserved Allosteric Site on Opioid Receptors[J]. Molecular Pharmacology, 2017:mol.117.109561.
molnova catalog
related products
  • Cannabidiol

    Cannabidiol is GPR55 and weak CB1 antagonist (IC50s: 0.445 and 3.35 μM) CB2 receptor inverse agonist and inhibitor of anandamide uptake (IC50: 27.5 μM). It also a weak agonist at VR1 vanilloid receptors (EC50: 3.5 μM).

  • Trimebutine CTB salt

    Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.

  • (20R)-Protopanaxdiol

    Protopanaxdiol has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity.